All the Latest Game Footage and Images from Kronos: Time Titan In this 2D combat platformer, embark on a quest to confront the God of the Sky as you navigate the dangers of Mount Olympus in order to ...

Five years ago, mathematicians Dawei Chen and Quentin Gendron were trying to untangle a difficult area of algebraic geometry involving differentials, elements of calculus used to measure distance ...

Korg just officially unveiled the Phase8 synthesizer, after years of tinkering by a team led by legendary engineer Tatsuya Takahashi. This is a highly experimental synthesizer, but it's not a concept ...

Ignota Labs has harvested more assets for its drug candidate rehabilitation scheme, snapping up Kronos Bio’s clinical pipeline months after a series of setbacks drove the biotech off public markets. U ...

The new Kronos IEMs from have nine drivers and a six-way crossover but an impedance of less than 35Ω. Noble Audio has announced the launch of its latest pair of flagship in-ear monitors. The Kronos ...

Today (July 16) marks the 80th anniversary of the Trinity test, during which a team of U.S. scientists led by J. Robert Oppenheimer detonated the world’s first atomic bomb in the deserts of New Mexico ...

Word problems try and tell students a story about the math problem in front of them. They are a useful way to connect abstract numbers to concrete situations, so students can learn early on to apply ...

Korg’s Nu:Tekt NTS-1 was a pleasant surprise when it arrived a few years ago. A DIY synth kit featuring a single monophonic digital oscillator, but with the ability to host custom sound engines ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Credit: Korg NAMM 2025: ...

In January 2020, just eight months into her tenure as CEO of Best Buy, Corie Barry learned about a novel coronavirus spreading in China. By early March, Barry was getting reports that the virus was ...

Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...

On the heels Kronos Bio’s decision to can its last remaining clinical asset earlier this month, the company said it would roll out “significant expense reduction strategies” to buy itself more time.